Phase I/II trial of cabazitaxel plus abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel and abiraterone
Titel:
Phase I/II trial of cabazitaxel plus abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel and abiraterone
Auteur:
Massard, C. Mateo, J. Loriot, Y. Pezaro, C. Albiges, L. Mehra, N. Varga, A. Bianchini, D. Ryan, C.J. Petrylak, D.P. Attard, G. Shen, L. Fizazi, K. de Bono, J.